Milestone Pharmaceuticals Enters Into Cooperation Agreement With Alta Fundamental Advisers
July 17, 2024
July 17, 2024
PALO ALTO, California, July 17 -- Cooley, a law firm, issued the following news release:
New York - July 15, 2024 - Cooley advised Milestone Pharmaceuticals (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, on its announced refreshment of its board of directors - consisting of the appointment of two independent directors, effective immediately, and the appointment of an additional independent director . . .
New York - July 15, 2024 - Cooley advised Milestone Pharmaceuticals (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, on its announced refreshment of its board of directors - consisting of the appointment of two independent directors, effective immediately, and the appointment of an additional independent director . . .